Akt and PTEN: beta-cell mass and pancreas plasticity
- PMID: 19541499
- PMCID: PMC4456182
- DOI: 10.1016/j.tem.2009.03.002
Akt and PTEN: beta-cell mass and pancreas plasticity
Abstract
The capacity of pancreatic beta-cells to adapt to insulin resistance is crucial for glucose homeostasis and is a factor in the development of type 2 diabetes. The insulin receptor substrate (insulin receptor 2/phosphoinositide 3-kinase [PI3K]) pathway plays a crucial part in regulating beta-cell mass and function. The serine-threonine kinase Akt, also known as protein kinase B, is one of the major downstream targets of the PI3K pathway and is negatively regulated by phosphatase and tensin homologue deleted on chromosome 10. This Akt signaling pathway has recently been implicated in cell-cycle progression and survival of pancreatic beta-cells. Understanding the mechanisms that link Akt to modulation of beta-cell mass, function and plasticity will positively affect treatment of human diabetes.
Figures
References
-
- Woodgett JR. Recent advances in the protein kinase B signaling pathway. Current opinion in cell biology. 2005;17:150–157. - PubMed
-
- Franke TF. Intracellular signaling by Akt: bound to be specific. Science signaling. 2008;1:pe29. - PubMed
-
- Cho H, et al. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. The Journal of biological chemistry. 2001;276:38349–38352. - PubMed
-
- Cho H, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (New York, N.Y. 2001;292:1728–1731. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
